|
|
 |
|
Viewing report
|
|
|
|
Neuroprotection in Stroke - Protecting the Brain Sells
Datamonitor, Jan 2005, Pages: 54
Stroke is one of the leading causes of death and adult disability worldwide. Nevertheless, acute treatments for stroke are severely limited. Neuroprotective drugs, which boast the ability to halt the ischemic cascade, offer huge hope to sufferers, but as yet, no such compound has received US approval. However, several promising compounds are currently in development.
Report Scope
Overview of the potential size of the ischemic stroke patient population
Examination of current clinical practice including diagnosis and both preventative and acute treatment for stroke
Evaluation of the opportunity for neuroprotective compounds in the potential treatment of stroke
Review of key products currently in development
Highlights
Poor patient awareness about the symptoms of stroke and delayed treatment by healthcare providers limits the number of patients eligible for acute treatment.
Successful neuroprotection is limited by the short window of opportunity for active intervention. A more in-depth understanding of the mechanisms involved in cell injury and death is needed to aid drug development.
The cascade of cell death is multi-faceted and although simple single target mechanisms have shown some efficacy in pre-clinical trials, a more complex multi targeted approach may prove more successful in patients.
Reasons to Purchase
Gain a top-line overview of the patient potential and current treatment in the stroke market
Understand the unmet need of neuroprotection in stroke
Evaluate future players in this market
Customers who bought this item also bought
Neuroprotection - Drugs, Markets and Companies
Pipeline Insight: Acute Stroke: Commercial Risk Offsets High Unmet Need
Stakeholder Insight: Acute Stroke - TPA Spurs Infrastructure Changes for the Better
Drugs of Tomorrow 2001: Neuroprotection - Future Strategies for Success
Acute Stroke - Considerable Unmet Need is Balanced by Substantial Commercial Risk
Antithrombotics in Acute Ischemic Stroke - The Clot Thickens
Drugs, Devices and Procedures of Tomorrow: Acute Stroke - Chasing the need for speed
TPA in Stroke: Treatment Patterns and Potential
Neuroprotective Agents: Eighth International Neuroprotection Society Meeting
Treatment Algorithms 2001: Stroke - Time is Brain
Acute Stroke - Symptom Awareness Will Reduce Headache
Target Product Profiles 2008: Physician Insights on Key Attributes - Acute Ischemic Stroke
|
|
|
|
